World's Best Scientists 2026 revealed!
Michael B. Ranke

Michael B. Ranke

D-Index & Metrics

Medicine

D-Index
93
Citations
30637
World Ranking
10923
National Ranking
593

Overview

Michael B. Ranke is affiliated with the University of Tübingen in Germany and works primarily in the field of Medicine. Their research focuses extensively on the subfield of Endocrinology, Diabetes, and Metabolism. Alongside this, they have contributed to research in Infectious Diseases, Epidemiology, Pediatrics, Perinatology, and Child Health, as well as Genetics.

The scientist's work encompasses topics related to Growth Hormone and Insulin-like Growth Factors, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Birth, Development, and Health, Regulation of Appetite and Obesity, Sexual Differentiation and Disorders, and Childhood Cancer Survivors' Quality of Life.

Recent publications authored or co-authored by Michael B. Ranke include:

  • Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort, 2022, The Journal of Clinical Endocrinology & Metabolism
  • Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency, 2021, Frontiers in Endocrinology
  • Accuracy and self-validation of automated bone age determination, 2022, Scientific Reports
  • Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients, 2020, Viruses
  • Kidney disease and thyroid dysfunction: the chicken or egg problem, 2022, Pediatric Nephrology

Frequent co-authors in their collaborations include:

  • Bertram Flehmig
  • Martin Wabitsch
  • Elżbieta Petriczko
  • S. Brandt
  • Michael P. Wajnrajch

Michael B. Ranke's work has been published repeatedly in several key scientific venues, reflecting their engagement across multiple disciplines. These venues include:

  • The Journal of Clinical Endocrinology & Metabolism
  • Viruses
  • Frontiers in Endocrinology
  • Journal of Clinical Research in Pediatric Endocrinology
  • Journal of Clinical Medicine

Best Publications

  • Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome

    Ercole Rao;Birgit Weiss;Maki Fukami;Maki Fukami;Andreas Rump

  • Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society

    Kenneth M. Attie;Bengt Ake Bengtsson;Sandra L. Blethen;Werner Blum

  • A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency.

    Werner F. Blum;Michael B. Ranke;Klaus Kietzmann;Elisabeth Gauggel

  • Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion

    W F Blum;K Albertsson-Wikland;S Rosberg;M B Ranke

  • Recommendations for the diagnosis and management of Turner syndrome

    P. Saenger;K. Albertsson Wikland;G. S. Conway;M. Davenport

  • Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study.

    Georg Brabant;Alexander von zur Mühlen;Christian Wüster;Michael B Ranke

  • Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I.

    W. F. Blum;E. W. Jenne;F. Reppin;K. Kietzmann

  • Turner syndrome: Spontaneous growth in 150 cases and review of the literature

    M. B. Ranke;H. Pflüger;W. Rosendahl;P. Stubbe

  • Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy

    Karl Josef Osterziel;Oliver Strohm;Jochen Schuler;Matthias Friedrich

  • Turner's syndrome

    Michael B Ranke;Paul Saenger

  • Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.

    Wayne S Cutfield;Patrick Wilton;Helge Bennmarker;Kerstin Albertsson-Wikland

  • Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3).

    Martin W Elmlinger;Werner Kühnel;Matthias M Weber;Michael B Ranke

  • Derivation and Validation of a Mathematical Model for Predicting the Response to Exogenous Recombinant Human Growth Hormone (GH) in Prepubertal Children with Idiopathic GH Deficiency

    Michael B. Ranke;Anders Lindberg;Pierre Chatelain;Patrick Wilton

  • Towards a consensus on the definition of idiopathic short stature.

    Michael B. Ranke

  • Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia.

    Werner F. Blum;Michael B. Ranke;Klaus Kietzmann;Burkhardt Tönshoff

  • Noonan syndrome: growth and clinical manifestations in 144 cases

    M. B. Ranke;P. Heidemann;C. Knupfer;H. Enders

  • Growth hormone — past, present and future

    Michael B. Ranke;Jan M. Wit

  • Growth and symptoms in Silver-Russell syndrome: Review on the basis of 386 patients

    H. A. Wollmann;T. Kirchner;H. Enders;M. A. Preece

  • Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults.

    Martin W. Elmlinger;Werner Kühnel;Michael B. Ranke

  • Increased mortality associated with growth hormone treatment in critically ill adults.

    K.J. Osterziel;R. Dietz;M.B. Ranke

Frequent Co-Authors

Werner F. Blum
Werner F. Blum University of Giessen
Jan M. Wit
Jan M. Wit Leiden University Medical Center
Kerstin Albertsson-Wikland
Kerstin Albertsson-Wikland University of Gothenburg
Thomas Eggermann
Thomas Eggermann RWTH Aachen University
Ron G. Rosenfeld
Ron G. Rosenfeld Oregon Health & Science University
David Price
David Price University of Aberdeen
David B. Dunger
David B. Dunger University of Cambridge
Wieland Kiess
Wieland Kiess Leipzig University
Oskar G. Jenni
Oskar G. Jenni University of Zurich
Thomas Reinehr
Thomas Reinehr Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in healthcare doesn’t always mean becoming a doctor. There are diverse online degree options that open doors to vital roles in medical settings. One popular choice is the healthcare administration degree online, preparing students for leadership positions in hospitals, clinics, and other healthcare organizations.

For those looking to advance, the most affordable online mha programs provide in-depth management training. These programs are designed for busy professionals aspiring to move into executive or specialized administrative roles.

Nursing professionals seeking the highest level of clinical expertise can consider a 1 year dnp program online. This doctorate pathway focuses on practical, evidence-based healthcare and leadership, ideal for nurses wanting to impact care delivery at the highest levels.

Interested in pharmaceuticals? An online pharmd programs pathway can lead to becoming a Doctor of Pharmacy, preparing you for advanced patient care roles. These flexible online options help build rewarding careers in medicine and healthcare, often at a lower cost and with greater convenience.

Best Scientists Citing Michael B. Ranke

Trending Scientists

Recently Published Articles